Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction
David Hasdai, MD*,
Robert M. Califf, MD, FACC ,
Trevor D. Thompson, BS ,
Judith S. Hochman, MD, FACC ,
E. Magnus Ohman, MD, FACC ,
Matthias Pfisterer, MD, FACC ,
Eric R. Bates, MD, FACC||,
Alec Vahanian, MD¶,
Paul W. Armstrong, MD, FACC#,
Douglas A. Criger, MPH ,
Eric J. Topol, MD, FACC** and
David R. Holmes, Jr., MD, FACC
* Rabin Medical Center, Petah Tikva, Israel
Duke University Medical Center, Durham, North Carolina, USA
St. Lukes/Roosevelt Hospital Center, New York, New York, USA
University Hospital Basel, Basel, Switzerland
|| University of Michigan Medical Center, Ann Arbor, Michigan, USA
¶ Hospital Tenon, Paris, France
# University of Alberta, Walter C. Mackenzie Health Center, Edmonton, Canada
** The Cleveland Clinic Foundation, Cleveland, Ohio, USA
 Mayo Clinic, Rochester, Minnesota, USA

View larger version (7K):
[in a new window]
|
Figure 1 The relationship between systolic blood pressure (BP) upon presentation and the probability of shock developing after thrombolytic therapy.
|
|

View larger version (8K):
[in a new window]
|
Figure 2 The relationship between heart rate upon presentation and the probability of shock developing after thrombolytic therapy.
|
|
|